Five Prime Therapeutics 2Q16 Earnings Update August 2016

Loading viewer...

earnings

Format: PDF earnings

Five Prime Therapeutics' second quarter 2016 earnings presentation dated August 4, 2016. The biotech company presents its oncology-focused pipeline including clinical candidates Cabiralizumab (FPA008), FPA144, and FP-1039 across multiple tumor indications.

Browse all earningss →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Five Prime Therapeutics

View all →

Five Prime Therapeutics 3Q16 Earnings Update November 2016

earnings

16 Pages

Five Prime Therapeutics_August_2017_657_12657

presentation

Similar earningss from other companies

Browse all →

Destination XL Q3 2016 Earnings Supplemental Information

earnings

12 Pages

Destination XL Group

BMPS 3Q16 Earnings Results October 2016

earnings